ZEISS ELYRA P.1 with 3D-PALM has been selected by the expert judges and editors of R&D Magazine as a recipient of a 2014 R&D 100 Award.
The patented exclusive PALM technology of ZEISS ELYRA P.1 is regarded as one of 100 most significant high-technology products introduced in the past year.
As its name suggests, the 3D-PALM module enables superresolution photoactivated localization microscopy (PALM) in 3D. With ELYRA P.1 and 3D-PALM, researchers can capture highly resolved structures in 3D using photo-switchable proteins, while treating the sample so gently it stays fit for long-term observation. Detection with an effective resolution down to 20 nm shows substructures and patterns where conventional light microscopy will simply show co-localization.
The technology has been supported by the Federal Ministry of Education and Research (German abbreviation: BMBF) as part of the project "Optical Technologies (biophotonics)".
The R&D 100 Awards celebrate the year's top technology products in the fields of new materials, chemical research, biomedical products and high-energy physics. The winners come from the areas of industry, science, private research institutes and government laboratories. Since 2002, ZEISS has won one of the renowned awards every year.
ZEISS
ZEISS is an international leader in the fields of optics and optoelectronics. The more than 24,000 employees of ZEISS generated revenue of about 4.2 billion euros in fiscal year 2012/13. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. ZEISS has been contributing to technological progress for more than 160 years. ZEISS develops and produces solutions for the semiconductor, automotive and mechanical engineering industries, biomedical research and medical technology, as well as eyeglass lenses, camera and cine lenses, binoculars and planetariums. ZEISS is present in over 40 countries around the globe with more than 40 production facilities, around 50 sales and service locations and over 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).